Induction by transforming growth factor-beta 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells

Eur J Immunol. 1994 Dec;24(12):3194-8. doi: 10.1002/eji.1830241242.

Abstract

The aim of this study was to examine the expression of interleukin-1 receptor antagonist (IL-1ra) in human polymorphonuclear cells (PMN) treated with transforming growth factor-beta 1 (TGF beta 1). TGF beta 1 induced IL-1ra transcripts in human circulating PMN and the induction was not blocked by protein synthesis inhibitors. Actinomycin D blocked induction by TGF beta 1 of IL-1ra transcripts, suggesting the involvement of gene transcription. The half life of IL-1ra transcripts was prolonged by TGF beta 1. By reverse transcriptase-polymerase chain reaction, TGF beta 1 was found to augment the transcripts coding for both the intracellular (keratinocyte type) and the secreted form of IL-1ra. TGF beta 1 induced the production of IL-1ra in PMN. Induction of IL-1ra by TGF beta 1 in PMN may represent a further mechanism by which this molecule can counteract the potent pro-inflammatory properties of IL-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • DNA Primers / chemistry
  • Gene Expression
  • Humans
  • In Vitro Techniques
  • Interleukin 1 Receptor Antagonist Protein
  • Molecular Sequence Data
  • RNA, Messenger / genetics
  • Sialoglycoproteins / biosynthesis*
  • Sialoglycoproteins / genetics
  • Transcription, Genetic
  • Transforming Growth Factor beta / pharmacology*

Substances

  • DNA Primers
  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • RNA, Messenger
  • Sialoglycoproteins
  • Transforming Growth Factor beta